Disappointing Results for Tirasemtiv in VITALITY-ALS Trial
Cytokinetics has reported negative results from its international phase 3 VITALITY-ALS trial to test the investigational drug tirasemtiv in people with ALS.
Cytokinetics has reported negative results from its international phase 3 VITALITY-ALS trial to test the investigational drug tirasemtiv in people with ALS.
Researchers are looking for people with MNDs like ALS to join a clinical trial for the investigational drug FLX-787-ODT.
Researchers are looking for people with ALS to participate in a phase 2 clinical trial for the investigational drug CK-2127107.
MDA has awarded a grant to Iron Horse Diagnostics to support development of a prognostic (predictive) test for ALS.
Chris Anselmo, who lives with an NMD, reports back from the 4th annual Strength, Science and Stories of Inspiration (SSSI)
Maya Maor Nof of Stanford University School of Medicine received the 2017 SSSI-MDA Fellowship Award to study ALS.
Researchers are looking for people with ALS to join a clinical trial to test the drug AMX0035.
In October 1986 Jerry Lewis announced the DMD gene had been discovered, a monumental moment in MD research.
Thanks in part to Dutch Bros. generous support, MDA is currently funding 38 active ALS grants, with a total funding commitment of $9.6 million.
Check out a full recording of the ALS Treatment Update: Radicava webinar. Radicava is now available in the U.S.